W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
|
Back to Search Results |
|
Catalog Number PXC121000 |
Device Problems
Premature Activation (1484); Material Separation (1562); Malposition of Device (2616)
|
Patient Problem
Occlusion (1984)
|
Event Date 11/30/2015 |
Event Type
Injury
|
Manufacturer Narrative
|
Concomitant products: patient medications: albuterol, prevecal, singulair, clonamax, hydrocodine, nitro-time, methimazole, procardin.The review of the manufacturing paperwork verified that the lot(s) met all pre-release specifications.(b)(4).
|
|
Event Description
|
On (b)(6) 2015, the patient was treated for an abdominal aortic aneurysm.It was reported that during the procedure a pxc121000 came apart at the trailing olive, which caused the graft and the leading olive to separate and the device to deploy prematurely in a location other than intended.It was reported the patient had very small vessels, and the physician had previously dilated the access vessels by implanting gore viabahn endoprosthesis.A 12fr sheath was used but could not be pushed to the intended location.It was reported the physician could not get device into the gate of the gore excluder aaa endoprosthesis so the pxc121000 was pulled back and that is when the device leading olive separated and the device deployed in an unintended location at the bifurcation covering the hypogastric artery.The physician snared the leading olive and catheter, he then bridged another endoprosthesis from the bifurcation to the gore excluder aaa endoprosthesis.The physician is choosing to wait and see how the patient tolerates the covered hypo gastric artery.The physician has requested a response from gore.The device catheter will be returned to gore for evaluation.
|
|
Manufacturer Narrative
|
According to the gore® excluder® aaa endoprosthesis instructions for use (ifu), iliac artery treatment diameter range of 8 ¿ 18.5 mm and iliac distal vessel seal zone length of at least 10 mm.Additionally the ifu states; do not rotate the contralateral leg delivery catheter during delivery, positioning or deployment.Catheter breakage or premature deployment may occur.Do not advance the device outside of the sheath.The sheath will protect the device from catheter breakage or premature deployment while tracking it into position.Do not continue advancing any portion of the delivery system if resistance is felt during advancement of the guidewire, sheath, or catheter.Stop and assess the cause of resistance.Vessel or catheter damage may occur.Do not attempt to withdraw any un-deployed endoprosthesis through the introducer sheath.The sheath and catheter must be removed together.
|
|
Manufacturer Narrative
|
Added engineering evaluation results: as part of the investigation of this event, an engineering evaluation has been completed.The pxc12100 was returned to gore for evaluation, the evaluation revealed the following: the leading end of the catheter had separated from the catheter body at the trailing olive.The guidewire lumen had fractured at the trailing olive bond on the catheter.There was a twist in the guidewire lumen which is indicative of the device being rotated.The root cause for the broken leading end of the catheter could not be determined with the currently available information, however, used outside the gore® excluder® aaa endoprosthesis instructions for use (ifu) likely contributed to the event.
|
|
Search Alerts/Recalls
|
|
|